Agentic AI that works the way clinicians do.
A growing suite of agentic and diagnostic AI tools — built to detect disease earlier, sharpen clinical decisions, and extend care across the population.
Liver disease tools
Agentic and multi-modal systems purpose-built for MASLD, MASH, and fibrosis — from biomarker discovery to bedside decision support.
LivFibro
Powerful AI-driven triaging for early detection of liver fibrosis.
LivFibro is an intelligent clinical decision support solution designed to identify patients at risk of clinically significant liver fibrosis (F2+) using routinely available healthcare data. By combining validated clinical scoring systems, rule-based reasoning, and advanced AI models, LivFibro enables early, accurate, and scalable risk stratification helping clinicians act before disease progression becomes irreversible.
LivRisk
A multi-modal digital liver platform that integrates omics, imaging, EHR, and clinical data for AI-driven diagnosis, risk prediction, and biomarker discovery.
LivRNA+
An automated AI engine that mines and analyzes large-scale public RNA-seq datasets to identify early-stage biomarkers for liver disease.
LivEst
An AI assessment tool that evaluates fatty liver disease risk through a personalized questionnaire.
Watch demo →
LivIQ
An agentic AI system that combines diagnostics, risk prediction, and research insights into a unified interface to enhance decision-making and care continuity for liver disease patients.
LivAid
A "biomarker validator" that provides expert information on liver conditions — particularly MASLD and MASH — by integrating advanced language understanding with knowledge graphs and retrieval.
Watch demo →